Q1FY22 Earnings Presentation

8 Strides 10 Steady performance in emerging markets, Q1FY22 revenues up 11% YoY Financial Performance (*/$M) QUARTER ON QUARTER 2,119 $29 529 YEAR ON YEAR 1,671 1,503 $23 $20 1,671 $23 OQ1 FY21 0Q1FY22 DQ4FY21 DQ1FY22 >>> - 21% QoQ >>> 11% YOY Business Updates Revenues from emerging markets for Q1FY22 stood at *1,671m ($23m), up 11% YoY, representing 24% of consolidated revenues for Q1FY22 The Africa business delivered a steady performance despite macro headwinds and lower demand for acute portfolio, the business reported revenues of ₹701m in Q1FY22, up 1% YoY Leveraging digital platforms for a better doctor connect, focus on new product introductions and improved MR productivity to drive next leg of growth for the Africa business Institutional business reported revenues of *970m in Q1FY22 up 20% YoY, sequential decline in revenues due to lumpy nature of the business While we have witnessed softness during Q1FY22, we expect growth to continue for the full year Re-looking the business to be a cost leader in the space with a strong product pipeline YoY comparison in INR reported

View entire presentation